{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:08:14Z","timestamp":1771510094116,"version":"3.50.1"},"reference-count":14,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"unspecified","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2026,1,3]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Cryptococcal meningitis (CM) is an infection of the central nervous system that accounts for approximately 19% of AIDS-related mortality worldwide, with the highest burden being in sub-Saharan Africa (SSA). In 2022, the WHO released clinical guidelines on the prevention, diagnosis and treatment of CM, based on strong evidence-based studies. It is not known how these WHO guidelines are being integrated at the national level. This study aims to highlight national clinical guidelines for the prevention, diagnosis and management of CM across SSA and how these guidelines compare to WHO 2022\u2009CM guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive search was conducted to gather the current national clinical CM guidelines from all 46 countries in SSA. Methods to acquire copies of national guidelines included using online search engines, official government websites, WHO country office websites, direct contact with WHO officials and officers in national ministries of health as well as surveying the data repository of the International AIDS Society and HIV Policy Lab\u2019s Advanced HIV Disease Dashboard. National CM guidelines were analysed to determine if they incorporated the recommendations in the 2022 WHO CM guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 46 countries in SSA, 37% (17\/46) did not have established national CM screening and diagnostic guidelines and 35% (16\/46) did not have established national CM treatment guidelines accessible through our methodology. Among the countries with CM guidelines, 21% (10\/46) follow WHO recommendations for prevention, 30% (14\/46) for diagnosis and 13% (6\/46) for treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite recent evidence to support diagnostic techniques and treatment approaches to improve CM outcomes, most national CM guidelines in SSA are not in accordance with the updated WHO recommendations, stressing a persistent gap in national adoption of CM international evidence-based guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgh-2025-019953","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:10:14Z","timestamp":1771506614000},"page":"e019953","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["An analysis of national guidelines for the prevention, diagnosis and treatment of cryptococcal meningitis in sub-Saharan African countries: gaps and opportunities"],"prefix":"10.1136","volume":"11","author":[{"given":"Ryan S","family":"Walker","sequence":"first","affiliation":[{"name":"Program in Neuroinfectious Diseases, New York-Presbyterian\/Columbia University Irving Medical Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6006-3909","authenticated-orcid":false,"given":"Gerome B","family":"Vallejos","sequence":"additional","affiliation":[{"name":"Program in Neuroinfectious Diseases, New York-Presbyterian\/Columbia University Irving Medical Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Temesgen","family":"Nurye","sequence":"additional","affiliation":[{"name":"Program in Neuroinfectious Diseases, New York-Presbyterian\/Columbia University Irving Medical Center, New York, New York, USA"},{"name":"Global Brain Health Institute, University of California San Francisco, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Kim","sequence":"additional","affiliation":[{"name":"Program in Neuroinfectious Diseases, New York-Presbyterian\/Columbia University Irving Medical Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agrata","family":"Sharma","sequence":"additional","affiliation":[{"name":"O\u2019Neill Institute for National and Global Health Law, Georgetown University, Washington, District of Columbia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-5869","authenticated-orcid":false,"given":"Mengistu Hagazi","family":"Tequare","sequence":"additional","affiliation":[{"name":"Mekelle University College of Health Sciences, Mek\u2019ele, Tigray, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraha","family":"Gebreegziabher","sequence":"additional","affiliation":[{"name":"Mekelle University College of Health Sciences, Mek\u2019ele, Tigray, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kibrom","family":"Gebrselassie","sequence":"additional","affiliation":[{"name":"Mekelle University College of Health Sciences, Mek\u2019ele, Tigray, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Lovero","sequence":"additional","affiliation":[{"name":"Department of Sociomedical Sciences, Columbia University Mailman School of Public Health, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blen","family":"Mamo","sequence":"additional","affiliation":[{"name":"Mekelle University College of Health Sciences, Mek\u2019ele, Tigray, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senay","family":"Gebremariam","sequence":"additional","affiliation":[{"name":"Mekelle University College of Health Sciences, Mek\u2019ele, Tigray, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran T","family":"Thakur","sequence":"additional","affiliation":[{"name":"Program in Neuroinfectious Diseases, New York-Presbyterian\/Columbia University Irving Medical Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"2026021905100818000_11.2.e019953.1","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(22)00499-6"},{"key":"2026021905100818000_11.2.e019953.2","unstructured":"World Health Organization . Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV, 2022. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240052178"},{"key":"2026021905100818000_11.2.e019953.3","unstructured":"The International AIDS Society . National policies. 2024. Available: https:\/\/www.differentiatedservicedelivery.org\/national-policies"},{"key":"2026021905100818000_11.2.e019953.4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-003695","article-title":"Understanding and comparing HIV-related law and policy environments: cross-national data and accountability for the global AIDS response","volume":"5","author":"Kavanagh","year":"2020","journal-title":"BMJ Glob Health"},{"key":"2026021905100818000_11.2.e019953.5","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2111904"},{"key":"2026021905100818000_11.2.e019953.6","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","article-title":"Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial","volume":"385","author":"Mfinanga","year":"2015","journal-title":"The Lancet"},{"key":"2026021905100818000_11.2.e019953.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158986","article-title":"Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa","volume":"11","author":"Larson","year":"2016","journal-title":"PLoS One"},{"key":"2026021905100818000_11.2.e019953.8","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S1473-3099(22)00656-9","article-title":"Diagnostic capacity for invasive fungal infections in advanced HIV disease in Africa: a continent-wide survey","volume":"23","author":"Lakoh","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2026021905100818000_11.2.e019953.9","unstructured":"World Health Organization . Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach Geneva, 2021. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240031593"},{"key":"2026021905100818000_11.2.e019953.10","doi-asserted-by":"crossref","DOI":"10.4102\/sajhivmed.v25i1.1560","article-title":"Lived experience of people with cryptococcal meningitis: A qualitative study","volume":"25","author":"Legare","year":"2024","journal-title":"South Afr J HIV Med"},{"key":"2026021905100818000_11.2.e019953.11","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1212\/WNL.0000000000001561","article-title":"Lumbar puncture refusal in sub-Saharan Africa: A call for further understanding and intervention","volume":"84","author":"Thakur","year":"2015","journal-title":"Neurology (ECronicon)"},{"key":"2026021905100818000_11.2.e019953.12","unstructured":"M\u00e9decins Sans Fronti\u00e8res . Liposomal amphotericin b: solving the access puzzle. M\u00e9decins Sans Fronti\u00e8res; 2022. Available: https:\/\/msfaccess.org\/sites\/default\/files\/2022-04\/IssueBrief_LAmB_update_April2022.pdf"},{"key":"2026021905100818000_11.2.e019953.13","doi-asserted-by":"crossref","first-page":"e1552","DOI":"10.1016\/S2214-109X(24)00225-0","article-title":"Paving the way for affordable and equitable liposomal amphotericin B access worldwide","volume":"12","author":"Lee","year":"2024","journal-title":"Lancet Glob Health"},{"key":"2026021905100818000_11.2.e019953.14","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS) . The urgency of now: AIDS at a crossroads Geneva, 2024. Available: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2024-unaids-global-aids-update_en.pdf"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2025-019953","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:10:17Z","timestamp":1771506617000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2025-019953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,19]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bmjgh-2025-019953"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2025-019953","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}